Research ArticleArticle
A Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab in Subjects with Rheumatoid Arthritis and an Inadequate Response to Methotrexate
Karel Pavelka, Yun Chon, Richard Newmark, Shao-Lee Lin, Scott Baumgartner and Ngozi Erondu
The Journal of Rheumatology June 2015, 42 (6) 912-919; DOI: https://doi.org/10.3899/jrheum.141271
Karel Pavelka
From the Institute of Rheumatology, Prague, Czech Republic; and Amgen Inc., Thousand Oaks, California,
USA.
Yun Chon
Richard Newmark
Shao-Lee Lin
Scott Baumgartner
Ngozi Erondu
REFERENCES
- 1.↵
- 2.↵
- López-Méndez A,
- Daniel WW,
- Reading JC,
- Ward JR,
- Alarcón GS
- 3.↵
- Yazici Y,
- Curtis JR,
- Ince A,
- Baraf H,
- Malamet RL,
- Teng LL,
- et al.
- 4.↵
- Cohen SB,
- Emery P,
- Greenwald MW,
- Dougados M,
- Furie RA,
- Genovese MC,
- et al;
- REFLEX Trial Group
- 5.↵
- Schiff M,
- Keiserman M,
- Codding C,
- Songcharoen S,
- Berman A,
- Nayiager S,
- et al.
- 6.↵
- Nam JL,
- Winthrop KL,
- van Vollenhoven RF,
- Pavelka K,
- Valesini G,
- Hensor EM,
- et al.
- 7.↵
- 8.↵
- Breedveld FC,
- Weisman MH,
- Kavanaugh AF,
- Cohen SB,
- Pavelka K,
- van Vollenhoven R,
- et al.
- 9.↵
- St Clair EW,
- van der Heijde DM,
- Smolen JS,
- Maini RN,
- Bathon JM,
- Emery P,
- et al;
- Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset Study Group
- 10.↵
- Lipsky PE,
- van der Heijde DM,
- St Clair EW,
- Furst DE,
- Breedveld FC,
- Kalden JR,
- et al;
- Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group
- 11.↵
- 12.↵
- Weinblatt ME,
- Keystone EC,
- Furst DE,
- Moreland LW,
- Weisman MH,
- Birbara CA,
- et al.
- 13.↵
- Finckh A,
- Simard JF,
- Gabay C,
- Guerne PA;
- SCQM physicians
- 14.↵
- 15.↵
- 16.↵
- Fossiez F,
- Djossou O,
- Chomarat P,
- Flores-Romo L,
- Ait-Yahia S,
- Maat C,
- et al.
- 17.↵
- 18.↵
- Ziolkowska M,
- Kurowska M,
- Radzikowska A,
- Luszczykiewicz G,
- Wiland P,
- Dziewczopolski W,
- et al.
- 19.↵
- 20.↵
- 21.↵
- 22.↵
- Genovese MC,
- Durez P,
- Richards HB,
- Supronik J,
- Dokoupilova E,
- Mazurov V,
- et al.
- 23.↵
- Genovese MC,
- Greenwald M,
- Cho CS,
- Berman A,
- Jin L,
- Cameron GS,
- et al.
- 24.↵
- Corneth OB,
- Mus AM,
- Asmawidjaja PS,
- Klein Wolterink RG,
- van Nimwegen M,
- Brem MD,
- et al.
- 25.↵
- 26.↵
- 27.↵
- 28.↵
- 29.↵
- Prevoo ML,
- van ‘t Hof MA,
- Kuper HH,
- van Leeuwen MA,
- van de Putte LB,
- van Riel PL
- 30.↵
- 31.↵
- 32.↵
In this issue
The Journal of Rheumatology
Vol. 42, Issue 6
1 Jun 2015
A Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab in Subjects with Rheumatoid Arthritis and an Inadequate Response to Methotrexate
Karel Pavelka, Yun Chon, Richard Newmark, Shao-Lee Lin, Scott Baumgartner, Ngozi Erondu
The Journal of Rheumatology Jun 2015, 42 (6) 912-919; DOI: 10.3899/jrheum.141271
A Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab in Subjects with Rheumatoid Arthritis and an Inadequate Response to Methotrexate
Karel Pavelka, Yun Chon, Richard Newmark, Shao-Lee Lin, Scott Baumgartner, Ngozi Erondu
The Journal of Rheumatology Jun 2015, 42 (6) 912-919; DOI: 10.3899/jrheum.141271